As the use of nanomaterials continues to rise in cosmetic formulations, regulatory expectations and scientific scrutiny are becoming increasingly stringent. The SCCS and ISO guidelines have outlined precise requirements for the characterisation and safety assessment of nanoparticles, placing new demands on manufacturers and R&D teams.
At Eurofins C&PC, we offer a comprehensive service portfolio tailored to ensure regulatory compliance and product safety when dealing with nanomaterials in cosmetic products. Our approach begins with formula stability and proceeds through a tiered evaluation process depending on the need for sample preparation (distribution, dispersion, etc.) in accordance with SCCS guidelines.
Depending on the formulation, we perform a sample preparation phase followed by in vitro safety testing under GLP: cytotoxicity, phototoxicity, irritation assays (eye, skin, vaginal, oral), sensitization, genotoxicity, chromosomal aberration, and more.
Moreover, when analytical characterisation is required, we leverage our accredited laboratories (ISO 17025, ISO 9001) to assess nanoparticles at an advanced level. This includes chemical composition, surface interactions and structure, agglomeration state, diameter, and physico-chemical properties via robust methodologies, and equipment (ICP-MS, SEM, TEM, etc.).
With deep expertise and cutting-edge infrastructure, Eurofins C&PC supports your innovation while ensuring full regulatory alignment, providing clarity in the complex field of nanomaterial testing.